As of December 31, 2021, cash and cash equivalents were €43.3 million and turnover was €1.0 million Success of Euronext Paris IPO in November 2021 with €35.7 million capital raised, after
MaaT Pharma becomes the first company developing microbiome-based drugs to be listed on the regulated market of Euronext Paris Capital increase of €31.5m and which could be increased to €36.2m
Université Paris-Saclay Master s Scholarships 2021/2022 for international study in France opportunitiesforafricans.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from opportunitiesforafricans.com Daily Mail and Mail on Sunday newspapers.